Compare Chemistree Technology, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 1 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.30
43.57%
-1.28
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
0 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
62.5%
0%
62.5%
6 Months
160.0%
0%
160.0%
1 Year
188.89%
0%
188.89%
2 Years
-82.67%
0%
-82.67%
3 Years
-82.67%
0%
-82.67%
4 Years
-98.27%
0%
-98.27%
5 Years
-98.98%
0%
-98.98%
Chemistree Technology, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.13%
EBIT Growth (5y)
13.71%
EBIT to Interest (avg)
-1.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
-0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.28
EV to EBIT
-0.98
EV to EBITDA
-0.98
EV to Capital Employed
-0.98
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Oct 2010
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.04%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.00
-0.00
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.00
-0.00
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 100.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.50
-0.60
16.67%
Interest
0.00
0.80
-100.00%
Exceptional Items
0.00
-2.80
100.00%
Consolidate Net Profit
-0.50
-4.20
88.10%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 88.10% vs -223.08% in Jun 2024
About Chemistree Technology, Inc. 
Chemistree Technology, Inc.
Pharmaceuticals & Biotechnology
Chemistree Technology Inc. is a Canada-based investment company that focuses on investing in the United States cannabis sector. The Company provides solutions for the regulated cannabis industry. The Company owns assets in Washington State used to operate the Sugarleaf brand, cannabis cultivation lands in California, interest in Humboldt County and California cannabis processing company. The Company holds interest in Pasha Brands. The Company’s subsidiaries include Chemistree Washington Ltd., CHM Desert LLC and American CHM Investments Inc.
Company Coordinates 
Company Details
Pacific Centre, Suite 810 - 609 Granville Street, P.O. Box 10322, VANCOUVER BC : V6C 2T4
Registrar Details






